Stocksigma LogoStocksigma Logo

Natco Pharma Secures In-Principle Stock Exchange Approvals for Rights Issue

Natco Pharma Limited received in-principle approval from both the National Stock Exchange of India and BSE Limited on 21st Sep'26 for its proposed rights

Natco Pharma Secures In-Principle Stock Exchange Approvals for Rights Issue

Natco Pharma Ltd 路 Rights Issue 路 22 Sept 2026, 4:14 am

Natco Pharma Secures In-Principle Stock Exchange Approvals for Rights Issue Natco Pharma Limited received in-principle approval from both the National Stock Exchange of India and BSE Limited on 21st Sep'26 for its proposed rights issue of fully paid-up equity shares. This regulatory clearance represents a key procedural milestone, enabling the company to advance its equity capital-raising process.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements